Idexx Reaches New 52-Week High (IDXX)

NEW YORK ( TheStreet) -- Idexx Laboratories (Nasdaq: IDXX) hit a new 52-week high Tuesday as it is currently trading at $89.50, above its previous 52-week high of $89.50 with 108,287 shares traded as of 12:34 p.m. ET. Average volume has been 253,900 shares over the past 30 days.

Idexx has a market cap of $4.85 billion and is part of the health care sector and drugs industry. Shares are up 14.3% year to date as of the close of trading on Monday.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. The company has a P/E ratio of 30.6, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Idexx as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, increase in net income, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Idexx Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Stocks Tumble as Trump Comments Lead to Worries Over China Trade Talks

Stocks Tumble as Trump Comments Lead to Worries Over China Trade Talks

Tiffany & Co. Sees a Strong Market in Asia

Tiffany & Co. Sees a Strong Market in Asia

Imagining the Stock Market in 10 Years

Imagining the Stock Market in 10 Years

Video: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Video: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss